These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28117136)

  • 1. Use of FEV
    Szczesniak R; Heltshe SL; Stanojevic S; Mayer-Hamblett N
    J Cyst Fibros; 2017 May; 16(3):318-326. PubMed ID: 28117136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic endpoints for clinical studies for cystic fibrosis.
    Stanojevic S; Ratjen F
    J Cyst Fibros; 2016 Jul; 15(4):416-23. PubMed ID: 27316663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker.
    Bakker EM; Borsboom GJ; van der Wiel-Kooij EC; Caudri D; Rosenfeld M; Tiddens HA
    Pediatr Pulmonol; 2013 Nov; 48(11):1081-8. PubMed ID: 23401260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting disease progression in cystic fibrosis.
    Breuer O; Caudri D; Stick S; Turkovic L
    Expert Rev Respir Med; 2018 Nov; 12(11):905-917. PubMed ID: 30173593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
    Rosenfeld M; VanDevanter DR; Ren CL; Elkin EP; Pasta DJ; Konstan MW; Morgan WJ;
    Pediatr Pulmonol; 2015 Sep; 50(9):856-62. PubMed ID: 26086901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Italian Cystic Fibrosis Register - Report 2010].
    Amato A; Ferrigno L; Salvatore M; Toccaceli V;
    Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European Cystic Fibrosis Patient Registry, 2007-2009.
    VanDevanter DR; Pasta DJ
    J Cyst Fibros; 2013 Dec; 12(6):786-9. PubMed ID: 23632449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis.
    Szczesniak RD; McPhail GL; Duan LL; Macaluso M; Amin RS; Clancy JP
    Ann Epidemiol; 2013 Dec; 23(12):771-7. PubMed ID: 24103586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific reference equations for lung function in patients with cystic fibrosis.
    Kulich M; Rosenfeld M; Campbell J; Kronmal R; Gibson RL; Goss CH; Ramsey B
    Am J Respir Crit Care Med; 2005 Oct; 172(7):885-91. PubMed ID: 15976373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries.
    Kim SO; Corey M; Stephenson AL; Strug LJ
    Thorax; 2018 May; 73(5):446-450. PubMed ID: 29434047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.
    Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A
    Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telemedicine Home Program in Patients with Cystic Fibrosis: Results after 10 Years.
    Murgia F; Bianciardi F; Solvoll T; Tagliente I; Bella F; Carestia A; Bella S
    Clin Ter; 2015; 166(6):e384-8. PubMed ID: 26794821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis.
    Vermeulen F; Proesmans M; Boon M; Havermans T; De Boeck K
    Thorax; 2014 Jan; 69(1):39-45. PubMed ID: 24021874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV
    Hoo ZH; Curley R; Campbell MJ; Walters SJ; Wildman MJ
    J Eval Clin Pract; 2018 Aug; 24(4):745-751. PubMed ID: 29901239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis.
    Flight WG; Bright-Thomas RJ; Tilston P; Mutton KJ; Guiver M; Morris J; Webb AK; Jones AM
    Thorax; 2014 Mar; 69(3):247-53. PubMed ID: 24127019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.
    Stanojevic S; Davis SD; Retsch-Bogart G; Webster H; Davis M; Johnson RC; Jensen R; Pizarro ME; Kane M; Clem CC; Schornick L; Subbarao P; Ratjen FA
    Am J Respir Crit Care Med; 2017 May; 195(9):1216-1225. PubMed ID: 27943680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory markers of lung disease in adult patients with cystic fibrosis.
    Levy H; Kalish LA; Huntington I; Weller N; Gerard C; Silverman EK; Celedón JC; Pier GB; Weiss ST
    Pediatr Pulmonol; 2007 Mar; 42(3):256-62. PubMed ID: 17245735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced survival in adult cystic fibrosis despite attenuated lung function decline.
    Keating C; Poor AD; Liu X; Chiuzan C; Backenroth D; Zhang Y; DiMango E
    J Cyst Fibros; 2017 Jan; 16(1):78-84. PubMed ID: 27522311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function comparison between two decades in cystic fibrosis children: A single centre study.
    Tridello G; Volpi S; Assael BM; Meneghelli I; Passiu M; Circelli M
    Pediatr Pulmonol; 2015 Dec; 50(12):1237-43. PubMed ID: 26422228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients.
    Conrad DJ; Bailey BA; Hardie JA; Bakke PS; Eagan TML; Aarli BB
    PLoS One; 2017; 12(12):e0190061. PubMed ID: 29261779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.